Twelve infants (six boys, six girls) with severe hypocalcaemic tetany or convulsions were seen over a three year period. Nine patients were symptomatic in the newborn period. Their hypocalcaemia was associated with hyperphosphataemia and very low concentrations of immunoreactive parathyroid hormone. None of the babies suffered from congenital cardiac disease. Cell mediated immunity, measured in five patients, was normal. There were no chromosomal abnormalities but all patients shared several dysmorphic features including deep set eyes, microcephaly, thin lips, beaked nose tip, external ear anomalies, micrognathia, and depressed nasal bridge. Mental retardation of varying degree was found in all patients. All had severe intrauterine and postnatal growth retardation. Four patients have died. The remaining eight patients are on treatment with vitamin D and calcium supplements with no change in their growth pattern. We believe that this association of congenital hypoparathyroidism with severe growth failure and dysmorphism represents a new syndrome.
Hypoparathyroidism represents a range of clinical and biochemical syndromes characterised by parathyroid hormone deficiency, hypocalcaemia, and hyperphosphataemia. Neonatal hypoparathyroidism is relatively common, occurring usually as a transient condition associated with well defined risk factors such as prematurity, perinatal asphyxia, and maternal diabetes.' Permanent congenital hypoparathyroidism is rare. Most cases are caused by defective embryogenesis of structures deriving from the third and fourth pharyngeal pouches and fourth branchial arch-namely the parathyroid glands, thymus, heart and aortic arch, and several facial structures. This constellation of findings is known as third-fourth pharyngeal pouch syndrome or DiGeorge's syndrome. 2 In the past three years we have identified 12 patients with an unusual syndrome of congenital hypoparathyroidism associated with severe growth failure and dysmorphic features quite distinctive from those of DiGeorge's syndrome. The description of their clinical findings and laboratory investigations is the subject of this report which was presented in part at the 58th Annual Meeting of the Society for Pediatric Research, Washington DC, May 1988.3
Patients and methods

RECOGNITION OF THE SYNDROME
The index case (case 1) was a 3 year old Saudi boy who was the product of a normal full term pregnancy and spontaneous vaginal delivery. His birth weight was 1500 g. Hypocalcaemic tetany was diagnosed in the first few days of life and was treated with oral calcium supplement and a vitamin D preparation. His parents were first degree cousins and had two older children in perfect health.
He was referred to our care at the age of 4 5 months because of repeated attacks of vomiting and convulsions. His weight was 2-5 kg and length 47 cm. Physical examination disclosed moderate dehydration and several dysmorphic features including microcephaly, micrognathia, thin lips, low set and posteriorly rotated ears, deep set eyes, depressed nasal bridge and beaked nose tip, and high arched palate. Examination of the heart and lungs showed no abnormalities and there was no abdominal visceromegaly. He had small hands and feet, micropenis, and unilateral cryptorchidism. He had normal blood urea nitrogen and creatinine concentrations and moderate hyponatraemia, which was corrected with appropriate treatment. His serum calcium concentration ranged from 1 5 to 1-7 mmol/l, and inorganic phosphate from 2-3 to 4-0 mmol/l. Parathyroid hormone, measured on five occasions, ranged between 10-30 pmol/l (normal 29-85 pmol/l) despite severe concomitant hypocalcaemia.
Two unrelated patients (cases 2 and 3) with similar phenotypic abnormalities had been seen by one of the authors (NAS) Severe growth failure and psychomotor delay has persisted in all patients despite normalisation of their biochemical abnormalities (table 4) . Four patients have died during the course of this study: two from intercurrent infection (pneumonia), the other two from unknown causes.
Discussion
We consider that these 12 patients represent a new syndrome because of the association of severe prenatal and postnatal growth retardation, similar dysmorphic features, and the early clinical presentation caused by hypoparathyroidism, which was diagnosed on the basis of hypocalcaemia, hyperphosphataemia, and low serum concentrations of immunoreactive parathyroid hormone. Further support for this view is found in the report of a group of patients from Kuwait with the same characteristics. 4 The most striking abnormalities shared by all our patients were the severe intrauterine (11/12) and postnatal growth retardation. Thus all patients have remained appeciably below the third centile for weight and height despite correction of their biochemical abnormalities with vitamin D treatment. Forced nasogastric feeding, tried in three patients, and parenteral nutrition in one, failed to promote any significant growth. This pronounced growth retardation may be appreciated by examining table 4, which shows the weight and height SD score of six long term survivors with this syndrome. In general height or length is more severely affected than weight. Case 2, the oldest in the series, weighed only 6-4 kg and measured 76 cm at 5-5 years of age.
All patients presented with several dysmorphic findings (table 3) . The craniofacial features impart such a characteristic appearance on these patients (figure) that some were diagnosed at first sight by house officers who had seen examples before. Microcephaly, deep set eyes, and thin lips were present in all patients. Beaking of nose tip, micrognathia, prominent forehead, and depressed nasal bridge were also very common abnormalities.
Several patients in the series were referred from other hospitals to exclude the diagnosis of DiGeorge's syndrome, which is also characterised by congenital hypoparathyroidism and facial dysmorphism. There are several differences between patients with DiGeorge's syndrome and those we have described. First, in DiGeorge's syndrome there is aplasia or hypoplasia of structures deriving from the third and fourth pharyngeal pouches leading to thymic aplasia and cellular immunodeficiency as well as hypoparathyroidism. 2 5 13 The pathophysiology of hypoparathyroidism in our patients and its association with the multiple abnormalities described remain elusive to us. With the available data, it is impossible to tell whether the parathyroid glands were absent or hypoplastic or whether they were present but not adequately producing or releasing parathyroid hormone into the circulation.
The mode of inheritance in this syndrome is most probably autosomal recessive. This is suggested by the equal occurrence in both sexes, the familial incidence, and the very high frequency of consanguinity. Of interest is the fact that seven of 12 families came from the western province of the country. It is conceivable that the mutant gene for this disease may have originated from that area. We hope that this report will stimulate the recognition of the syndrome in other families and elsewhere. If, as seems probable, there is a high gene dose for the syndIome in the Kingdom of Saudi Arabia, collaboration between the paediatricians involved will improve the chance of identifying the genotype. As parathyroid hormone deficiency in some cases of familial hypoparathyroidism has been shown to be unrelated to the structural gene for parathyroid hormone,'4 15 the same may apply to the syndrome we have described.
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